首页> 美国卫生研究院文献>Gynecologic Oncology Reports >An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers

【2h】

An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers

机译：eRBB2受体抑制剂在阴道初级标志 - 环细胞腺癌腺癌S310F体细胞α2突变中的含蓄案例：乳腺癌和妇科癌症S310F体细胞α2突变的病例报告及综述文献

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Gynecologic Oncology Reports
作者
June Y. Hou; Jason D. Wright; Vuthinun Achariyapota;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 5
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers [J] . June Y. Hou, Jason D. Wright, Vuthinun Achariyapota Gynecologic Oncology Reports . 2020,第2期

机译：eRBB2受体抑制剂在阴道初级标志 - 环细胞腺癌腺癌S310F体细胞α2突变中的含蓄案例：乳腺癌和妇科癌症S310F体细胞α2突变的病例报告及综述文献
2. Successful treatment of a patient with Li-Fraumeni syndrome and metastatlc lung adenocarcinoma harboring synchronous EGFR L858R and ERBB2 extracellular domain S310F mutations with the pan-HER Inhibitor afatinib [J] . Yuxia Jia, Siraj M Ali, Shumaila Saad, Cancer biology & therapy . 2014,第8期

机译：使用pan-HER抑制剂afatinib成功治疗具有同步EGFR L858R和ERBB2细胞外域S310F突变的Li-Fraumeni综合征和转移性肺腺癌的患者
3. Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：可定位的ERBB2突变独立地预测初级，ERBB2未扩增的激素受体阳性小叶乳腺癌的侵袭性表型
4. Comprehensive proteomic analyses of the effects of a novel mutation in the ErbB2 tyrosine kinase domain on breast cancer metastasis [C] . Jane OHara, Juergen Kast American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：综合蛋白质组学分析ErbB2酪氨酸激酶结构域对乳腺癌转移的影响
5. Successful treatment of a patient with Li–Fraumeni syndrome and metastatic lung adenocarcinoma harboring synchronous EGFR L858R and ERBB2 extracellular domain S310F mutations with the pan-HER inhibitor afatinib [O] . Yuxia Jia, Siraj M Ali, Shumaila Saad, 2014

机译：使用pan-HER抑制剂afatinib成功治疗具有同步EGFR L858R和ERBB2胞外域S310F突变的Li-Fraumeni综合征和转移性肺腺癌患者
6. An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers [O] . June Y. Hou, Jason D. Wright, Vuthinun Achariyapota 2020

机译：eRBB2受体抑制剂在阴道初级标志 - 环细胞腺癌腺癌S310F体细胞α2突变中的含蓄案例：乳腺癌和妇科癌症S310F体细胞α2突变的病例报告及综述文献

An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers

著录项

相似文献

相关主题

期刊订阅